258 related articles for article (PubMed ID: 10461605)
1. Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging.
Levine MG; Ahlberg AW; Mann A; White MP; McGill CC; Mendes de Leon C; Piriz JM; Waters D; Heller GV
J Nucl Cardiol; 1999; 6(4):389-96. PubMed ID: 10461605
[TBL] [Abstract][Full Text] [Related]
2. Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease.
Shanoudy H; Raggi P; Beller GA; Soliman A; Ammermann EG; Kastner RJ; Watson DD
J Am Coll Cardiol; 1998 Feb; 31(2):331-7. PubMed ID: 9462576
[TBL] [Abstract][Full Text] [Related]
3. Impact of limited treadmill exercise on adenosine Tc-99m sestamibi single-photon emission computed tomographic myocardial perfusion imaging in coronary artery disease.
Jamil G; Ahlberg AW; Elliott MD; Hendel RC; Holly T; McGill CC; Sarkis M; White MP; Mather JF; Waters DD; Heller GV
Am J Cardiol; 1999 Aug; 84(4):400-3. PubMed ID: 10468076
[TBL] [Abstract][Full Text] [Related]
4. Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease.
Soman P; Taillefer R; DePuey EG; Udelson JE; Lahiri A
J Am Coll Cardiol; 2001 Feb; 37(2):458-62. PubMed ID: 11216963
[TBL] [Abstract][Full Text] [Related]
5. Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi.
Borges-Neto S; Tuttle RH; Shaw LK; Smith WT; Jain D; Coleman RE; Whellan D
Radiology; 2004 Jul; 232(1):58-65. PubMed ID: 15220493
[TBL] [Abstract][Full Text] [Related]
6. [Myocardial perfusion scintigraphy with Tc-99m MIBI in patients with left bundle branch block: Visual quantification of the anteroseptal perfusion imaging for the diagnosis of left anterior descending artery stenosis].
Möller J; Warwick J; Bouma H
Cardiovasc J S Afr; 2005; 16(2):95-101. PubMed ID: 15915276
[TBL] [Abstract][Full Text] [Related]
7. Tc-99m tetrofosmin myocardial perfusion SPECT after dipyridamole combined with low-level exercise in the diagnosis of coronary artery disease.
Fukuzawa S; Ozawa S; Inagaki M; Inoue T; Morooka S; Sugioka J
Ann Nucl Med; 1996 May; 10(2):231-5. PubMed ID: 8800453
[TBL] [Abstract][Full Text] [Related]
8. Assessment of adenosine, arbutamine and dobutamine as pharmacological stress agents during (99m)Tc-tetrofosmin SPECT imaging: a randomized study.
Wright DJ; Williams SG; Lindsay HS; Sheard KL; Thorley PJ; Sivananthan UM
Nucl Med Commun; 2001 Dec; 22(12):1305-11. PubMed ID: 11711900
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
Flamen P; Bossuyt A; Franken PR
J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
[TBL] [Abstract][Full Text] [Related]
10. Dobutamine technetium-99m tetrofosmin SPECT imaging for the diagnosis of coronary artery disease in patients with limited exercise capacity.
Elhendy A; Sozzi FB; Valkema R; van Domburg RT; Bax JJ; Roelandt JR
J Nucl Cardiol; 2000; 7(6):649-54. PubMed ID: 11144480
[TBL] [Abstract][Full Text] [Related]
11. Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease.
Matsunari I; Fujino S; Taki J; Senma J; Aoyama T; Wakasugi T; Hirai J; Saga T; Tonami N; Hisada K
Am J Cardiol; 1996 Feb; 77(5):350-4. PubMed ID: 8602561
[TBL] [Abstract][Full Text] [Related]
12. Technetium 99m-labeled tetrofosmin myocardial tomography in patients with coronary artery disease: comparison between adenosine and dynamic exercise stress testing.
Cuocolo A; Nicolai E; Soricelli A; Pace L; Nappi A; Sullo P; Cardei S; Argenziano L; Ell PJ; Salvatore M
J Nucl Cardiol; 1996; 3(3):194-203. PubMed ID: 8805739
[TBL] [Abstract][Full Text] [Related]
13. Technetium-99m sestamibi and tetrofosmin myocardial single-photon emission tomography: can we use the same reference data base?
Widding A; Hesse B; Gadsboll N
Eur J Nucl Med; 1997 Jan; 24(1):42-5. PubMed ID: 9044875
[TBL] [Abstract][Full Text] [Related]
14. Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging.
Smanio PE; Watson DD; Segalla DL; Vinson EL; Smith WH; Beller GA
J Am Coll Cardiol; 1997 Dec; 30(7):1687-92. PubMed ID: 9385894
[TBL] [Abstract][Full Text] [Related]
15. Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events.
Schinkel AF; Elhendy A; van Domburg RT; Bax JJ; Vourvouri EC; Bountioukos M; Rizzello V; Agricola E; Valkema R; Roelandt JR; Poldermans D
Am J Cardiol; 2003 Feb; 91(4):408-11. PubMed ID: 12586253
[TBL] [Abstract][Full Text] [Related]
16. Dipyridamole-dobutamine stress with Tc-99m sestamibi tomographic myocardial perfusion imaging.
Shehata AR; Ahlberg AW; White MP; Mann A; Fleming IA; Levine MG; Mather JF; Waters D; Heller GV
Am J Cardiol; 1998 Aug; 82(4):520-3. PubMed ID: 9723645
[TBL] [Abstract][Full Text] [Related]
17. Eleven-year prognostic value of dobutamine stress (99m)Tc-sestamibi myocardial perfusion imaging in patients with limited exercise capacity.
Boiten HJ; van Domburg RT; Valkema R; Schinkel AF
Am J Cardiol; 2015 Apr; 115(7):884-9. PubMed ID: 25661571
[TBL] [Abstract][Full Text] [Related]
18. Assessing coronary artery disease with dipyridamole technetium-99m-tetrofosmin SPECT: a multicenter trial.
He ZX; Iskandrian AS; Gupta NC; Verani MS
J Nucl Med; 1997 Jan; 38(1):44-8. PubMed ID: 8998148
[TBL] [Abstract][Full Text] [Related]
19. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease.
Acampa W; Cuocolo A; Sullo P; Varrone A; Nicolai E; Pace L; Petretta M; Salvatore M
J Nucl Cardiol; 1998; 5(3):265-74. PubMed ID: 9669581
[TBL] [Abstract][Full Text] [Related]
20. Prediction of 14-year cardiovascular outcomes by dobutamine stress
Roest S; Boiten HJ; van Domburg RT; Valkema R; Schinkel AFL
J Nucl Cardiol; 2018 Feb; 25(1):63-71. PubMed ID: 27381341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
